Tess Egginton
News
Pioneer Group and Novo Nordisk team up on Golden Ticket Programme for cardiometabolic health...
Pioneer Group, a specialist in life science infrastructure and venture building, has teamed up with global healthcare company Novo Nordisk to launch a Golden...
New Advanced Therapy Treatment Centre established in London to improve clinical trial infrastructure
The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy...
FDA approves Lilly’s EBGLYSS for adults and children 12 years and older with moderate-to-severe...
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's EBGLYSS (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults...
